SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-040467
Filing Date
2008-02-28
Accepted
2008-02-27 21:35:59
Documents
12
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1257353
2 MANUFACTURING, MARKETING AND SALES AGREEMENT dex1030.htm EX-10.30 291030
3 AMENDED AND RESTATED COLLABORATION AGREEMENT dex1031.htm EX-10.31 194208
4 MEMBERS AGREEMENT dex1032.htm EX-10.32 105619
5 SUBSIDIARIES OF BIOMARIN dex211.htm EX-21.1 2199
6 CONSENT OF KPMG LLP dex231.htm EX-23.1 2539
7 CONSENT OF PRICEWATERHOUSECOOPERS, LLP dex232.htm EX-23.2 1731
8 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 8265
9 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 8232
10 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex321.htm EX-32.1 4016
11 BIOMARIN/GENZYME LLC CONSOLIDATED FINANCIAL STATEMENTS dex991.htm EX-99.1 165341
12 GRAPHIC g89458g10j56.jpg GRAPHIC 35027
  Complete submission text file 0001193125-08-040467.txt   2090320
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26727 | Film No.: 08648299
SIC: 2834 Pharmaceutical Preparations